Showing results (361-370 of 587) with videos related to

Sort By:
Pageof 59
JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
The Lancet. Respiratory Medicine|April 9, 2021
Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 studyTimothy A Yap, Kazuhiko Nakagawa, Nobukazu Fujimoto, et al.
Future Oncology (London, England)|May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerFelix Nensa, Jörg Stattaus, Bruno Morgan, et al.
Virchows Archiv : an International Journal of Pathology|February 25, 2021
Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC studyVincent Thomas de Montpreville, Audrey Mansuet-Lupo, Cécile Le Naoures, et al.
Nature Medicine|February 4, 2022
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerLisa Derosa, Bertrand Routy, Andrew Maltez Thomas, et al.
Cancer Discovery|January 20, 2023
Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural MesotheliomaFrançois-Xavier Danlos, Matthieu Texier, Bastien Job, et al.
Clinical Lung Cancer|December 17, 2023
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung CancerMariona Riudavets, Edouard Auclin, Miguel Mosteiro, et al.
JCO Oncology Practice|February 23, 2021
Intercontinental Multidisciplinary Oncology Videoconferencing for Rare and Complex Cancer: An Alternative to Systematic TransferCharles Honoré, Olivier Mir, Arthur Geraud, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2018
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group surveyAntonin Levy, Corinne Faivre-Finn, Baktiar Hasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2019
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung CancerGonzalo Recondo, Laura Mezquita, Francesco Facchinetti, et al.
Pageof 59